Robert V. House

MONY Life Insurance Co. is based in New York, NY. Part of Dai-ichi Life Holdings, Inc., MONY Life Insurance Co. is a company that provides life insurance services. The company was founded in 1842. The CEO is Christopher Mark Condron. MONY Life Insurance was acquired by Protective Life Insurance Co. from AXA SA on October 01, 2013 for $1,060 million.

Unified Financial Services, Inc. provides financial products and services. It offers back-office and shareholder services for the assets of third-party mutual fund families, as well as its affiliated series funds, including mutual fund distribution services. The company was founded in 1989 and is headquartered in Lexington, KY.

Ixion Biotechnology, Inc. develops somatic cellular therapies to treat diabetes. The company was founded by Weaver H. Gaines and David C. Peck on April 4, 1994 and is headquartered in Alachua, FL.

Benvenue Medical, Inc. engages int the provision and development of invasive systems for spine repair. It offers Kiva an implant solution for vertebral augmentation and a departure from balloon kyphoplasty, Blazer-C a vertebral augmentation system that utilizes a unique cannulated curved wire offering mechanical channel creation, and Luna a interbody implant that is delivered through a minimally-invasive cannula to the disc space and expands in-situ. The company was founded by Laurent B. Schaller in 2004 and is headquartered in Santa Clara, CA.

KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC.

Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC.

Pacira Cryotech, Inc. develops novel technologies for treatment of peripheral nerves. Its iovera treatment harnesses the power of cold with the Focused Cold Therapy delivery system and delivers immediate results for both therapeutic and aesthetic applications. The firm’s iovera treatment does not use toxins, chemicals, or pharmaceuticals to achieve results and leaves nothing behind in the body. The company was founded by Lisa Elkins in 2005 and is headquartered in Fremont, CA.

Xhale, Inc. operates as a medical technology company. It develops and commercializes patient-centric monitoring solutions for the healthcare industry. The firm specializes in biotechnology, medical devices, clinical trials monitoring, and breath diagnostics. The company was founded by Richard J. Melker and Donn M. Dennis in 2005 and is headquartered in Gainesville, FL.

EndoShape, Inc. commercializes medical devices. Its products include Medusa multicoil, animation and instructions, and computerized tomography (CT) imaging. The company was founded by Harold Tyber, Jeffrey Cstleberry and Robin Shandas in 2006 and is headquartered in Idaho Springs, CO.

Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC.

TrueMotion Spine, Inc. manufactures medical devices. The firm focuses on the next generation of total disc replacement technology including patented cervical and lumbar disc replacement devices to preserve and restore the natural motion of the human spine. The firm has a suite of intellectual property covering the spinal implant designs which is positioned to bring unique products to the clinical community. The company was founded by Keith L. Doty and Stephanie H. Warrington in 2011 and is headquartered in Gainesville, FL.

PQ Bypass, Inc. develops novel procedure for the treatment of peripheral vascular diseases. It offers an approach for achieving a bypass of the femoral artery that is designed to match the performance and safety of an invasive surgery for long segment occlusions. The company was founded by Richard Heuser and James D. Joye in 2009 and is headquartered in Sunnyvale, CA.

OBMedical Co. operates as a medical device company. It offers a wireless electrode-based electronic maternal-fetal monitoring sensor replacement system that measures labor contractions, heart rates, and uterine contractions. The company was founded by Neil R. Euliano and Weaver H. Gaines in 2012 and is headquartered in Newberry, FL.

Innocrin Pharmaceuticals Holdings LLC discovers and develops oral inhibitors for the treatment of Castration-Resistant Prostate Cancer (CRPC). The company is headquartered in Durham, NC.

BioStratum, Inc. develops and distributes pharmaceutical products. Its products are used for treatment of diabetes and diabetic complications. The firm also develops anti-tumor, cancer, diabetic kidney disease and diabetic eye disease drugs. The company was founded by Karl Tryggvason and J. Wesley Fox in 1994 and is headquartered in Durham, NC.

Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH.

Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA.

BioFlorida, Inc. is an organization that represents the life science industry in Florida. The private company is based in Florida and represents over 6,700 establishments and research organizations in the biopharmaceutical, medical technology, and bioagriculture sectors, providing employment to 94,000 Floridians. The American company's initiatives aim to create a favorable business environment for the development of innovative products and technologies that enhance people's lives and bring economic benefits to the state. Nancy K. Bryan has been the CEO of the company since 2013.

Thyssen-Bornemisza Group is a Monegasque company that specializes in transporting and storing chemical gases.

Synogen Inc (Synogen) is a venture capital firm founded in 2003 by Jamie M. Grooms and Richard R. Allen. The firm is headquartered in Gainesville, Florida.

Spiracur, Inc. develops innovative wound healing technologies. Its products include smart negative pressure wound care system that includes cartridge, hydrocolloid dressing, and interface layer for the treatment of chronic and acute wounds; and ciSNaP closed incision systems, including sterile cartridges, controlled tension relief layers, advanced surgical dressing, and straps for patients undergoing high-risk procedures, including orthopedic, abdominal, vascular, and podiatric surgeries. The company was founded by Kenton D. Fong and Moshe Pinto in 2007 and is headquartered in Sunnyvale, CA.

Torrey Pines Institute for Molecular Studies, Inc. operates as a non-profit research center. The firm conducts research in various fields including: multiple sclerosis, cancer, heart disease, types I and II diabetes, macular degeneration, pain management, alzheimer's disease, inflammatory disorders, AIDS and other infectious diseases, regenerative medicine, obesity, transplant rejection, muscle wasting syndrome, rheumatoid arthritis and new methods for drug discovery. The company was founded by Dr. Richard A. Houghten in 1988 and is headquartered in Port St. Lucie, FL.

Resilience Government Services, Inc. engages in the development of biopharmaceutical products and medical devices. It also offers preclinical and clinical development, formulation optimization, and cGMP manufacturing. The company was founded by James D. Talton in 1999 and is headquartered in Alachua FL.

kSep Systems LLC provides automated single-use bioprocessing solutions to the clients in the areas of recombinant therapeutics, cell therapy and vaccines manufacturing. The company was founded by Sunil Mehta and Joseph T. McMahon in 2011 and is headquartered in Morrisville, NC.

Anaconda Biomed SL manufactures healthcare devices. It develops catheters for mechanical thrombectomies. The company was founded by Marc Ribo and Ofir Arad and is headquartered in Barcelona, Spain.

Tenon Technology AG manufactures surgical appliances. It develops joint fixation which stabilizes the joint via press fit without the use of crews. The company is headquartered in Schlieren, Switzerland.

Altis Biosystems, Inc. operates as a biotechnology company. It develops patent-pending stem cell technology that recreates the human intestinal epithelium. The firm offers products such as RepliGut Planar and RepliGut Crypt. The company was founded by Michael Biron, Christopher Sims, Nancy Allbritton, Scott Magness and Yuli Wang and is headquarterd in Chapel Hill, NC.

Propella Therapeutics, Inc. is an American biopharmaceutical company that has developed a platform combining medicinal chemistry with lymphatic targeting to create best- or first-in-class oncology drugs that have validated MOAs and biological targets but suffer from efficacy and safety limitations. Propella is based in an undisclosed location and is dedicated to meeting the needs of cancer patients currently underserved by existing standards of care. The company is currently in the phase 1 portion of a phase 1/2a study of its lead product candidate, PRL-02, for the treatment of metastatic prostate cancer. The company was founded by William E. Peterson, Charles Birbara, Milt V. Peterson, and the CEO is William Moore.

Florida Research Consortium engages in research and development. The private company is based in Tallahassee, FL. Jack Sullivan has been the CEO of the company since 2003.

Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC.